Contactless biometric verification from in-air signatures using deep siamese networks. [PDF]
Salturk S, Pamukcu TE, Kahraman N.
europepmc +1 more source
ABSTRACT Introduction Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) have demonstrated significant weight‐reducing effects and may offer benefits in idiopathic intracranial hypertension (IIH); however, recent concerns about the risk of non‐arteritic anterior ischemic optic neuropathy (NAION) have emerged.
Faisal A. Al‐Harbi +9 more
wiley +1 more source
A privacy-preserving cloud storage framework with hybrid encryption, homomorphic keyword search, and blockchain-based integrity verification. [PDF]
Ahmed HMA, Zubair S, Tawfik M, Tawfik M.
europepmc +1 more source
Sertraline Treatment Can Mimic Niemann‐Pick Type C Biomarker Profile: A Diagnostic Pitfall
ABSTRACT Background Oxysterols (cholestane‐3β,5α,6β‐triol and 7‐ketocholesterol) and N‐palmitoyl‐O‐phosphocholineserine (PPCS) are sensitive biomarkers for Niemann‐Pick disease type C (NPC) screening. However, false‐positive results occur, with a biomarker profile suggestive of NPC despite the absence of pathogenic variants in genes involved in NPC or ...
Maria Makrygianni +19 more
wiley +1 more source
VeriFed: Temporally Consistent Continuous Cross-Chain Data Federation. [PDF]
Hao K, Bi M, Ma Y.
europepmc +1 more source
Association Between Motor Pathway Damage and Motor Deficit in Upper and Lower Limb in People With MS
ABSTRACT Objective Corticospinal tract damage is common in people with MS, but the degree of clinical symptoms varies. We hypothesize that corticospinal tract lesions are more extensive and severe in people with MS with motor impairments in both upper and lower limbs.
Mathilde Liffran +13 more
wiley +1 more source
Secured framework for IoT based healthcare application. [PDF]
Nagavel V +3 more
europepmc +1 more source
Post-quantum cognitive zero trust architecture for healthcare IoT devices. [PDF]
Hussain H, Mishra S, Alshenaifi R.
europepmc +1 more source
A Quantum Proxy Signature Scheme Without Restrictions on the Identity and Number of Verifiers. [PDF]
Xiong S.
europepmc +1 more source

